Table 1:
Cohort Demographics by Race
| Total | Black | White | p-value* | ||||
|---|---|---|---|---|---|---|---|
| n or mean | % or SD | n or mean | % or SD | n or mean | % or SD | ||
| Size of Groups | 6,374 | 100 | 1,070 | 17.0 | 5,304 | 83.0 | - |
|
| |||||||
| Outcome | |||||||
|
| |||||||
| Patient received MOUD within 180 days of OUD diagnosis (n, %)† | 3,004 | 47.1 | 318 | 29.7 | 2,686 | 50.6 | 0.000 * |
|
| |||||||
| Controls | |||||||
|
| |||||||
| Gender (n, %) | |||||||
| Female | 2,906 | 45.6 | 411 | 38.4 | 2,495 | 47.0 | 0.000 * |
| Male | 3,468 | 54.4 | 659 | 61.6 | 2,809 | 53.0 | |
| Age Group (n, %) | |||||||
| 18-29 | 1,811 | 28.4 | 189 | 17.7 | 1,622 | 30.6 | 0.000 * |
| 30-39 | 2,183 | 34.2 | 228 | 21.3 | 1,955 | 36.9 | |
| 40-49 | 1,156 | 18.1 | 256 | 23.9 | 900 | 17.0 | |
| 50-64 | 1,224 | 19.2 | 397 | 37.1 | 827 | 15.6 | |
| Eligibility Group (n, %) | |||||||
| Expansion | 2,325 | 36.5 | 299 | 27.9 | 2,026 | 38.2 | 0.000 * |
| SSI | 1,737 | 27.3 | 481 | 45.0 | 1,256 | 23.7 | |
| Other | 2,312 | 36.3 | 290 | 27.1 | 2,022 | 38.1 | |
|
| |||||||
| Potential Mediators in 180 Days After OUD Diagnosis § | |||||||
|
| |||||||
| Mental Health Diagnosis (n, %) | 2,266 | 35.6 | 400 | 37.4 | 1,866 | 35.2 | 0.170 |
| Non-OUD SUD Diagnosis (n, %) | 1,710 | 26.8 | 428 | 40.0 | 1,282 | 24.2 | 0.000 * |
| HIV Diagnosis (n, %) | 8 | 0.1 | 4 | 0.4 | 4 | 0.1 | 0.012 * |
| HCV Diagnosis (n, %) | 340 | 5.3 | 40 | 3.7 | 300 | 5.7 | 0.011 * |
| Any SUD treatment utilization (non-MOUD) (n, %) | 4,368 | 68.5 | 728 | 68.0 | 3640 | 68.6 | 0.705 |
| Intensive SUD treatment utilization (non-MOUD) (n, %) | 2,367 | 37.1 | 420 | 39.3 | 1947 | 36.7 | 0.116 |
| Days in Allegheny County Jail (Mean, SD) | 8.93 | 31.4 | 14.18 | 40.4 | 7.87 | 29.1 | 0.000 * |
| Days in Court, Drug Offenses (Mean, SD) | 0.12 | 0.4 | 0.08 | 0.3 | 0.13 | 0.4 | 0.001 * |
| Days in Court, Nondrug Offenses (Mean, SD) | 0.21 | 0.5 | 0.18 | 0.5 | 0.22 | 0.6 | 0.029 * |
| Months with Child Welfare Involvement (Mean, SD) | 0.31 | 1.2 | 0.41 | 1.4 | 0.29 | 1.2 | 0.004 * |
| Months with Housing Support (Mean, SD) | 0.39 | 1.4 | 0.99 | 2.1 | 0.27 | 1.2 | 0.000 * |
| Days in Inpatient Setting (Mean, SD) | 0.84 | 4.1 | 1.27 | 5.9 | 0.75 | 3.7 | 0.002 * |
| Days in ED (Mean, SD) | 1.39 | 2.8 | 1.91 | 4.1 | 1.28 | 2.5 | 0.000 * |
P-value for differences in proportions between Black and White enrollees in the cohort. Differences were assessed using Chi-square tests for categorical variables and t-tests for continuous variables. Asterisks indicate statistical significant, p<.05.
MOUD included buprenorphine, methadone, and naltrexone and was identified using a combination of physical health, behavioral health, and pharmacy claims paid by Pennsylvania Medicaid and by Allegheny County.
We constructed mediators based on a review of evidence on 1) the association between race and health diagnoses and public service system contact, and 2) the association between health status measures and public service system contact and initiation of MOUD.